Site Search
Professionals 314 results
Capabilities 62 results
Practice Area
Our nationally recognized Appellate & Critical Motions (ACM) Practice delivers sophisticated legal advocacy and analysis before trial, at trial, and on appeal. From state trial courts to the U.S. Supreme Court, our ACM attorneys identify, preserve, and present the critical legal issues that can make the difference between winning and losing.
Practice Area
Trial skills matter—even in a world where few disputes ever see the inside of a courtroom. Winston has built a reputation as a trial lawyers’ firm, featuring seasoned litigators who leverage extensive courtroom experience to meet our clients’ business and legal objectives. Our long history of taking cases to trial—and winning—provides our clients with tremendous settlement leverage with their adversaries, as well as a substantial likelihood of a favorable resolution if, and when, they go to trial.
Practice Area
For decades, Winston has represented a broad array of clients in the insurance industry, including some of the world’s largest and best-known insurers. Our prowess in and understanding of the insurance industry encompasses not only its products, practices, and services, but also the increasing challenges posed by a world increasingly characterized by a fast-evolving technological landscape as well as financial, political, and environmental instability. Accordingly, Winston’s lawyers are among the most sought-after in the industry—not only by companies currently facing high-stakes litigations and investigations, but by those looking to take preventive action now in order to mitigate and manage their risk in the future.
Experience 128 results
Experience
|September 22, 2025
Winston Paris advised the founders and shareholders of Bylaw, on its acquisition by Septeo
Founded in 2019 by Adrien Aboudaram and Tuan Ardouin, Bylaw has developed next-generation AI technology to automate the processing of legal and financial documents. With a team primarily dedicated to R&D, the legaltech company aims to become the leading AI reference for regulated professions.
Experience
|September 10, 2025
$1.05 Billion PECO Energy Company Public Offering of First and Refunding Mortgage Bonds
We served as underwriters' counsel to BNY Capital Markets, Citigroup, PNC Capital Markets LLC, Scotiabank, US Bancorp, Mizuho and MUFG, as joint book-running managers, in connection with the registered public offering of $1.05 billion of First and Refunding Mortgage Bonds by PECO Energy Company comprised of $525 million 4.875% First and Refunding Mortgage Bonds due 2035 and $525 million 5.650% First and Refunding Mortgage Bonds due 2055.
Experience
|September 9, 2025
Winston & Strawn LLP represented Greenland Exploration Limited in a landmark business combination with Pelican Acquisition Corporation (NASDAQ: PELI) and March GL Company. The transaction, structured as a merger agreement, will result in the formation of Greenland Energy Company, expected to be publicly listed on NASDAQ under the ticker symbol “GLND.” Winston advised Greenland Exploration on all aspects of the deal, including regulatory strategy, corporate structuring, and negotiation of the merger terms.
Insights & News 3,361 results
Winston’s Environmental Law Update
|October 30, 2025
|5 Min Read
E15 Gasoline: Legal Landscape and Recent Legislative Updates
The EPA establishes a national standard for gasoline volatility (Reid vapor pressure, or RVP) via section 211(h) of the Clean Air Act to reduce emissions of volatile organic compounds.
Winston’s AI Top 10
|October 2025
|5 Min Read
Winston’s AI Monthly Recap - October 2025
Winston’s AI Top 10 summarizes the latest AI developments in the legal industry.
Sponsorship
|October 27, 2025
Winston & Strawn Sponsors Tokyo Forum on U.S. Capital, Digital Assets, and AI Innovation
Winston & Strawn is proud to sponsor the upcoming Beyond Borders, Beyond Markets Tokyo Forum on U.S. Capital, Digital Assets, and AI Innovation. This event brings together global investors to explore the future of finance—from IPO strategies to AI’s role in capital markets. The forum will discuss the nuances of going public in America and offer key considerations for capital access and enhanced liquidity.
Other Results 43 results
Site Content
In the product liability context, epidemiology refers to the study of the incidence, distribution, and etiology of disease or harm in human populations. Epidemiological studies include a variety of different study designs, such as prospective and retrospective cohort studies, case-control studies, randomized controlled trials, and meta-analysis. Epidemiology is a critical, and sometimes mandatory, element for establishing general causation.
Site Content
In the product liability context, general causation is the legal and scientific determination of whether the product in question has the inherent capability to cause the alleged injury under certain circumstances. Establishment of general causation is a critical aspect of a plaintiff’s case, and typically requires scientific evidence, such as epidemiology or toxicology, and expert testimony to establish a causal connection between the product’s design, manufacturing, or warnings and the injury or injuries at issue. As contrasted to specific causation, the focus in a general causation inquiry is on whether the product or exposure, as a general matter, can cause the type of injury claimed by the plaintiff. A general causation inquiry does not assess any facts unique to a particular plaintiff.